Same industry
TEVA against four drug peers, a year at 100
TEVA +97.6%. Merck +61.8%, Eli Lilly +36.1%, Johnson & Johnson +35.7%, AbbVie +12.4%. Weekly closes, Oct 3, 2025 = 100, log scale.
Share this chartEnd-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in TEVA’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.